- Home
- FONR vs QNCX Comparison
FONR vs QNCX Comparison
Compare FONR & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FONR
- QNCX
- Stock Information
- Founded
- FONR 1978
- QNCX 2012
- Country
- FONR United States
- QNCX United States
- Employees
- FONR N/A
- QNCX N/A
- Industry
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FONR Health Care
- QNCX Health Care
- Exchange
- FONR Nasdaq
- QNCX Nasdaq
- Market Cap
- FONR 99.1M
- QNCX 92.3M
- IPO Year
- FONR 1987
- QNCX 2019
- Fundamental
- Price
- FONR $15.46
- QNCX $1.88
- Analyst Decision
- FONR
- QNCX Strong Buy
- Analyst Count
- FONR 0
- QNCX 3
- Target Price
- FONR N/A
- QNCX $9.67
- AVG Volume (30 Days)
- FONR 17.4K
- QNCX 286.7K
- Earning Date
- FONR 12-24-2024
- QNCX 11-13-2024
- Dividend Yield
- FONR N/A
- QNCX N/A
- EPS Growth
- FONR N/A
- QNCX N/A
- EPS
- FONR 1.42
- QNCX N/A
- Revenue
- FONR $102,006,089.00
- QNCX N/A
- Revenue This Year
- FONR N/A
- QNCX N/A
- Revenue Next Year
- FONR N/A
- QNCX N/A
- P/E Ratio
- FONR $11.07
- QNCX N/A
- Revenue Growth
- FONR 0.70
- QNCX N/A
- 52 Week Low
- FONR $14.05
- QNCX $0.51
- 52 Week High
- FONR $24.05
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- FONR 44.50
- QNCX 52.02
- Support Level
- FONR $15.21
- QNCX $1.80
- Resistance Level
- FONR $15.74
- QNCX $2.09
- Average True Range (ATR)
- FONR 0.42
- QNCX 0.21
- MACD
- FONR -0.08
- QNCX -0.05
- Stochastic Oscillator
- FONR 16.44
- QNCX 27.01
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.